HiberCell Closes $67.4 Million Series B Financing and Secures $30 Million Debt Facility from Hercules Capital Proceeds to advance pipeline of clinical product candidates focused on preventing cancer relapse and metastasis NEW YORK, May 19, 2021 (GLOBE NEWSWIRE) -- HiberCell, a biotechnology company...